Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice

IBD, a chronic inflammatory disease, has been manifested as a growing health problem. No Crohn’s and Colitis councils have officially ratified anti-depressants as a routine regimen for IBD patients. However, some physicians empirically prescribe them to rectify functional bowel consequences such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatamnejad, Mohammad Reza, Baradaran Ghavami, Shaghayegh, Shirvani, Marzieh, Asghari Ahmadabad, Mona, Shahrokh, Shabnam, Farmani, Maryam, Sherkat, Ghazal, Asadzadeh Aghdaei, Hamid, Zali, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583131/
https://www.ncbi.nlm.nih.gov/pubmed/36275739
http://dx.doi.org/10.3389/fimmu.2022.980189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583131/
https://www.ncbi.nlm.nih.gov/pubmed/36275739
http://dx.doi.org/10.3389/fimmu.2022.980189

Ejemplares similares